Procter & Gamble: Still Too Expensive To Buy This Dip With A Recession Likely Approaching

Sep. 21, 2022 3:23 PM ETThe Procter & Gamble Company (PG)5 Comments


  • P&G stock has pulled back significantly from its April 2022 highs. Despite that, its valuations are still expensive, despite worsening global macro headwinds.
  • Procter & Gamble's CPG market leadership has helped investors perform remarkably well over the past ten years. However, investors need to focus on the future and not its past performance.
  • We postulate that P&G could benefit from cost tailwinds in H1'23 as the global supply chain eases further, while commodity prices and freight rates have pulled back sharply.
  • We discuss why investors should continue sitting on the sidelines and not buy this dip.
  • I do much more than just articles at Ultimate Growth Investing: Members get access to model portfolios, regular updates, a chat room, and more. Learn More »
Collection of popular food logos companies printed on paper

rvlsoft/iStock Editorial via Getty Images


Long-term investors in The Procter & Gamble Company (NYSE:PG) have generated highly consistent returns from the leading consumer packaged goods company worldwide. Its highly consistent 5Y (10.8%) and 10Y (10.3%) total return CAGR is a testament to the market's confidence in its long-term strategy. Therefore, we believe significant dips in PG's valuations offer substantial opportunities for investors to add more positions if the valuations are reasonable.

PG has fallen markedly in 2022, with a YTD total return of -14.5%. However, we deduce that its valuations are not attractive, even though it's likely at a near-term bottom. While P&G could recover its growth cadence from FY23, we find it challenging to justify a Buy rating at the current levels. Therefore, a worse-than-expected recessionary theme could hamper the recent easing of supply chain headwinds.

As a result, we believe it's appropriate for us to remain cautious on PG and reiterate our Hold rating for now.

PG's Valuations Remain Expensive

PG NTM EBITDA multiples valuation trend

PG NTM EBITDA multiples valuation trend (koyfin)

As seen above, PG last traded at an NTM EBITDA multiple of 16.7x, markedly above its 10Y mean of 14.5x. Notably, it's still within the one standard deviation zone above its 10Y mean, despite its fall from its 2021 highs.

Investors should consider that PG faced significant selling pressure at the two standard deviation zone above its 10Y mean, which also coincided with its tops in December 2021 and April 2022. Therefore, we postulate the reward-to-risk balance is not attractive at the current levels amid worsening macro headwinds.

PG NTM Dividend yield % valuation trend

PG NTM Dividend yield % valuation trend (koyfin)

Moreover, its NTM dividend yield of 2.57% also seems relatively low compared to its 10Y mean and is unlikely sufficient to help undergird its valuations at the current levels.

Management Remains Confident Of Its Execution

P&G is a well-managed company that has executed remarkably well over the years. Therefore, management has strong credibility with investors, coupled with the revenue visibility offered by its more defensive product categories.

Notwithstanding, the company is not immune to global macroeconomic pressures, exacerbated by its weak performance in China. Therefore, we believe PG's relative weakness in 2022 reflects consumer spending challenges as the market parsed the impact on P&G's medium-term outlook.

P&G EBIT margins % and Gross margins % consensus estimates

P&G EBIT margins % and Gross margins % consensus estimates (S&P Cap IQ)

P&G's pricing leadership and strong competitive moat have helped mitigate the pressure against its margins profile. Therefore, its gross margins have been relatively stable, even though it has fallen markedly from FQ4'21. P&G has also been impacted by the global supply chain headwinds and inflationary pressure, exacerbated by geopolitical tensions.

Notwithstanding, the consensus estimates (bullish) indicate that P&G's margins could have reached a nadir in FQ4'22 (ended June 2022 quarter). It projects a reacceleration in its margins profile through FY23, which could undergird the recovery of its operating leverage.

Management's commentary at a recent September conference also corroborated its confidence in potentially less intense costs headwinds moving ahead. CFO Andre Schulten accentuated:

We see some good news on commodity input costs sequentially. So that's a little bit of help versus the numbers that were underlying our guidance. Transportation in the US is easing a little bit. The two forces that work against that [are] pass-through from suppliers in terms of floor pack material costs as they are working through their cost challenges. (Barclays Global Consumer Staples Conference)

SPGSCI price chart (weekly)

SPGSCI price chart (weekly) (TradingView)

We are confident that P&G could see some cost mitigation tailwinds in H1'23. The GSCI Commodity Index (SPGSCI) has continued to moderate through September, driven by the looming threat of a global recession.

Also, we discerned that the global supply chain pressure fell off the cliff in August, reverting to early 2021 levels. Moreover, global freight costs have collapsed nearly 35% over the past three months as the market adjusted its expectations of potentially significant demand destruction from elevated freight rates. While it's still well above pre-COVID levels, it could help mitigate some of the demand pressure from a weaker consumer outlook.

Is PG Stock A Buy, Sell, Or Hold?

PG price chart (monthly)

PG price chart (monthly) (TradingView)

Our assessment of PG's long-term price action suggests that it has a clear long-term uptrend. Therefore, we believe it demonstrates the market's high confidence level in P&G's market leadership and strong competitive moat. However, we noted that PG could re-test its June lows, which should provide critical clues to its medium-term directional bias.

While we are not bearish on PG, we don't find the current levels as attractive, despite its sharp pullback from its April 2022 highs.

Accordingly, we reiterate our Hold rating on PG and urge investors to continue watching from the sidelines.

Do you want to buy only at the right entry points for your growth stocks?

We help you to pick lower-risk entry points, ensuring you are able to capitalize on them with a higher probability of success and profit on their next wave up. Your membership also includes:

  • 24/7 access to our model portfolios

  • Daily Tactical Market Analysis to sharpen your market awareness and avoid the emotional rollercoaster

  • Access to all our top stocks and earnings ideas

  • Access to all our charts with specific entry points

  • Real-time chatroom support

  • Real-time buy/sell/hedge alerts

Sign up now for a Risk-Free 14-Day free trial!

This article was written by

JR Research profile picture
Sifting through the ultimate growth stocks for your portfolio

I'm JR, the lead writer and founder of JR Research and Ultimate Growth Investing Marketplace service. Our team is committed to bringing more clarity to investors in their investment decisions.

Our marketplace service focuses on a price-action-based approach to growth and technology stocks, supported by fundamental analysis. In addition, our general SA site discusses stocks from various sectors and industries. 

Our discussion mainly focuses on a short- to medium-term thesis. While we hold stocks for the long-term, we also use appropriate opportunities to benefit from short- to medium-term swings, leveraging long (directionally bullish) or short (directionally bearish) set-ups. 

My LinkedIn:

Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Recommended For You

Comments (5)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.